SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001096906-22-002334
Filing Date
2022-09-23
Accepted
2022-09-23 16:27:28
Documents
1
Period of Report
2020-05-13

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4430
  Complete submission text file 0001096906-22-002334.txt   5935
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Issuer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 ROCKERFELLER PLACE, 20TH FLOOR SUITE 83 NEW YORK NY 10111
Business Address
Cunningham Robert L (Reporting) CIK: 0001708731 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54296 | Film No.: 221262647